Tissue Engineering & Stem Cell Technology Report 2007VisiongainFebruary 28, 2007 71 Pages - SKU: VSG1471310 |
|
Stem Cell Research Products: Opportunities, Tools, & Technologies
5/1/2012 | published by: BioInformant Worldwide, L.L.C.
Overview: With recent advances in induced pluripotent stem cells (iPSC) creating excitement in stem cell research circles and U.S. President Obama expanding the number of human embryonic stem cell lines (hESC) available for federally
|
more...
|
$3,495.00
|
|
European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2012 (21 countries)
3/1/2012 | published by: iData Research, Inc.
In 2011, the European markets for bone graft substitute, dental membranes and tissue engineering products approached €248 million. Austria, Benelux (comprising Belgium, the Netherlands and Luxemburg), Czech Republic France, Germany,
|
more...
|
$11,495.00
|
|
Mesenchymal Stem Cells - Advances & Applications
4/1/2012 | published by: BioInformant Worldwide, L.L.C.
Overview: Analysis of global grant activity, scientific publication rates, and patent applications reveal that research activity involving mesenchymal stem cells increased 58% year-over-year from 2008 to 2009, and 112% from 2009 to 2010.
|
more...
|
$3,995.00
|
|
Capitalizing on Opportunities in Cord Blood Industry Growth
4/1/2012 | published by: BioInformant Worldwide, L.L.C.
Overview: Over the past 12 months, the cord blood banking industry has expanded through double digit growth, due to new entrants in the cord blood banking industry, as well as revenue growth at existing
|
more...
|
$3,995.00
|
|
Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)
1/1/2012 | published by: Kalorama Information
There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells
|
more...
|
$3,995.00
|
|
World Wound Care Markets 2011
6/1/2011 | published by: Kalorama Information
The wound care industry is a highly diverse and competitive arena - including everything from standard products such as dry bandages to sophisticated hydrogels and alginate dressings, and encompassing artificial skin and anti-infectives used in
|
more...
|
$1,995.00
|
|
Tissue Engineering: The Combination of Cells & Engineering - A Global Market Overview
2/15/2012 | published by: Industry Experts
Advancements of novel therapies in the fields of tissue engineering and regenerative medicine have opened up new avenues for addressing a range of major diseases such as cancer; skin; cardiovascular conditions; urology; dental; neurological disorders
|
more...
|
$3,600.00
|
|
Genetic Engineering
1/1/2012 | published by: Global Industry Analysts
The global outlook series on Genetic Engineering provides a collection of market briefs and concise summaries of research findings. The report offers an aerial view of the industry, highlights latest developments, and discusses demand drivers,
|
more...
|
$1,995.00
|
|
Cord Blood Database
2/23/2012 | published by: BioInformant Worldwide, L.L.C.
CORD BLOOD DATABASE - Comprehensive Industry Database (2012)
Have you heard that the cord blood banking is expanding with double-digit growth and wondered how you could benefit from that trend?
|
more...
|
$995.00
|
|
Strategic Development of Neural Stem & Progenitor Cell Products
1/1/2012 | published by: BioInformant Worldwide, L.L.C.
Overview: Neurogenesis is the process by which neurons are created. This process is most active during pre-natal development when neurogenesis is responsible for populating the growing brain. Neural stem cells (NSCs) are the self-renewing,
|
more...
|
$3,495.00
|
Related Markets
Stem Cell Reports
- Stem Cell Research Products: Opportunities, Tools, & Technologies
- Mesenchymal Stem Cells - Advances & Applications
- Capitalizing on Opportunities in Cord Blood Industry Growth
- Strategic Development of Neural Stem & Progenitor Cell Products
- Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2012
